Cautious on Yahoo! ...
Services: Diversified Services
Genetic Technologies Limited (GENE: NASDAQ)
$3.11 0.13 | 4.36%
05/23/13 - 04:00 PM ET
Company Balance Sheet
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 9.11M | 5.46M | 2.81M | 6.32M |
| Receivables | 507.93K | 720.74K | 641.36K | 1.48M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 2.83K | 60.90K | 0.00 |
| Total Current Assets | 10.19M | 6.69M | 3.83M | 8.15M |
| Property, Plant & Equipment, Gross | 6.37M | 6.15M | 2.85M | 6.98M |
| Accumulated Depreciation & Depletion | 5.71M | 5.14M | 1.17M | 4.55M |
| Property, Plant & Equipment, Net | 658.41K | 1.01M | 1.68M | 2.43M |
| Intangibles | 1.15M | 1.50M | 1.26M | 3.72M |
| Other Non-Current Assets | 4.52M | 0.00 | 0.00 | 205.80K |
| Total Non-Current Assets | 6.65M | 2.85M | 3.21M | 6.36M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 16.84M | 9.54M | 7.04M | 14.51M |
| Accounts Payable | 927.60K | 1.19M | 1.02M | 1.74M |
| Short Term Debt | 18.18K | 72.54K | 325.19K | 301.39K |
| Other Current Liabilities | 758.24K | 725.88K | 600.17K | 821.88K |
| Total Current Liabilities | 1.98M | 2.16M | 2.11M | 3.05M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 111.16K | 88.42K | 70.48K | 69.65K |
| Minority Interest | -9.53K | -9.26K | -9.72K | -13.92K |
| Total Non-Current Liabilities | 269.51K | 304.31K | 227.26K | 194.54K |
| Total Liabilities | 2.25M | 2.47M | 2.33M | 3.24M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 14.59M | 7.07M | 4.70M | 11.26M |
| Common Par | 85.29M | 77.36M | 61.51M | 57.53M |
| Additional Paid In Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -74.50M | -72.10M | -58.11M | -46.27M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 3.81M | 1.81M | 1.30M | 0.00 |
| Total Capitalization | 14.59M | 7.07M | 4.70M | 11.26M |
| Total Equity | 14.59M | 7.07M | 4.70M | 11.26M |
| Total Liabilities & Stock Equity | 16.84M | 9.54M | 7.04M | 14.51M |
| Total Common Shares Outstanding | 15.49M | 13.49M | 13.49M | 12.49M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 15.35M | 13.49M | 12.70M | 12.46M |
| Diluted Weighted Shares Outstanding | 15.35M | 13.49M | 12.70M | 12.46M |
| Number of Employees | 64 | 58 | 54 | 65 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with GENE
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor14 Penny Stocks Get Delisti...
- UserExperimental Equities
- UserMBW
- Userann's prorfolio
Latest GENE Headlines from TheStreet
- STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE 04.15.13 | 12:04 pm
- The Centers For Women's Health In Stamford CT Pioneers Breast Cancer Risk Assessment 03.18.13 | 12:03 pm
- 5 Stocks Ready to Break Out 02.22.13 | 12:02 pm
- 4 Stocks Under $10 Making Big Moves 10.19.12 | 02:10 pm
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
- Optimer Soars on Antibiotic Data 11.11.08 | 12:11 pm
- Biotech Buzz: Big Strides in Alzheimer's Drugs
01.10.08 | 05:01 pm - Funny Money 12.10.07 | 01:12 pm
- Ties May Bind Apple's CEO to Board 09.06.06 | 04:09 pm
Press Releases for GENE
- BREVAGen Reclassified 64% Of Intermediate Gail Risk Subjects(1) (Graphic: Business Wire) - Business Wire 04.10.12 | 09:04 am
- Break-Through Invention For Treating Cancer - Business Wire 11.07.11 | 10:11 am
- Genetic Technologies Limited Announces Quarterly Activities Report For The Quarter Ended 30 September 2011 - Business Wire 10.26.11 | 11:10 am
- Genetic Technologies’ BREVAGen™ Changing The Way US Physicians Assess Breast Cancer Risk - Business Wire 10.18.11 | 09:10 am
- Genetic Technologies Limited Appoints Dr. Mervyn Cass As Company Director - Business Wire 10.03.11 | 10:10 am
Partner Headlines for GENE
- Morning Market Losers - Benzinga 11.28.12 | 09:11 am
- Genetic Technologies Executes Covenant Not to Sue And Release Agreement with One Lambda - Benzinga 10.18.12 | 01:10 pm
- 3 Best Biotech Stocks For This Week (Part VI) - Seeking Alpha 10.16.12 | 08:10 am
- Morning Market Movers - Benzinga 09.25.12 | 09:09 am
- Genetic Technologies Moving On News This Morning - Seeking Alpha 08.08.12 | 09:08 am
- Healthcare Business Recap: Merck's Potential AIDS CURE, Genetic Tech SPIKES - Wall St. Cheat Sheet 07.27.12 | 08:07 am
- Genetic Technologies Executes Exclusive Distribution Agreement with Rosetta Genomics - Benzinga 06.01.12 | 01:06 pm
- Netflix, Take-Two Among Stocks Attracting Investors and Traders Now - Wall St. Cheat Sheet 05.23.12 | 02:05 am
- Afternoon Market Top Percentage Gainers and Losers (CAAS, GENE, HNSN, SYMX, TPX, SCOK, QXM, IDIX, AIB, HERO) - Benzinga 04.08.11 | 01:04 pm
